Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase

Virology

Volumn 379, Issue 2, 2008, Pages 223-233

  Konsavage Jr , Wesley M ^a   Sudol, Malgorzata ^a   Katzman, Michael ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Disordered loop; Integrase; Integration; Replication; Retrovirus; Rous sarcoma virus

Indexed keywords

INTEGRASE; MAGNESIUM;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL CULTURE; CHEMICAL REACTION; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; CELL LINE; CHICKENS; DNA, VIRAL; HIV INTEGRASE; HIV-1; INTEGRASES; MAGNESIUM; MOLECULAR SEQUENCE DATA; MUTAGENESIS; QUAIL; ROUS SARCOMA VIRUS; VIRUS REPLICATION;

ROUS SARCOMA VIRUS;

EID: 50349096775     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.07.001     Document Type: Article

References (94)

1. Asante-Appiah E., and Skalka A.M. A metal-induced conformational change and activation of HIV-1 integrase. J. Biol. Chem. 272 (1997) 16196-16205
2. Avidan O., and Hizi A. Expression and characterization of the integrase of bovine immunodeficiency virus. Virology 371 (2008) 309-321
3. Barreca M.L., Lee K.W., Chimirri A., and Briggs J.M. Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance. Biophys. J. 84 (2003) 1450-1463
4. Bock C.W., Katz A.K., Markham G.D., and Glusker J.P. Manganese as a replacement for magnesium and zinc: functional comparison of the divalent ions. J. Am. Chem. Soc. 121 (1999) 7360-7372
5. Brigo A., Lee K.W., Fogolari F., Mustata G.I., and Briggs J.M. Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitor. Proteins 59 (2005) 723-741
6. Brigo A., Lee K.W., Iurcu Mustata G., and Briggs J.M. Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain. Biophys. J. 88 (2005) 3072-3082
7. Brown P.O., Bowerman B., Varmus H.E., and Bishop J.M. Correct integration of retroviral DNA in vitro. Cell 49 (1987) 347-356
8. Bujacz G., Alexandratos J., Wlodawer A., Merkel G., Andrake M., Katz R.A., and Skalka A.M. Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. J. Biol. Chem. 272 (1997) 18161-18168
9. Bujacz G., Jaskolski M., Alexandratos J., Wlodawer A., Merkel G., Katz R.A., and Skalka A.M. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 253 (1995) 333-346
10. Bujacz G., Jaskolski M., Alexandratos J., Wlodawer A., Merkel G., Katz R.A., and Skalka A.M. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure 4 (1996) 89-96
11. Bukrinsky M.I., Sharova N., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G., Haggerty S.A., and Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6580-6584
12. Bushman F.D., Engelman A., Palmer I., Wingfield P., and Craigie R. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 3428-3432
13. Chen J.C.H., Krucinski J., Miercke L.J.W., Finer-Moore J.S., Tang A.H., Leavitt A.D., and Stroud R.M. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8233-8238
14. Chow S.A., Vincent K.A., Ellison V., and Brown P.O. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 255 (1992) 723-726
15. Courcot B., Firley D., Fraisse B., Becker P., Gillet J.M., Pattison P., Chernyshov D., Sghaier M., Zouhiri F., Desmaele D., d'Angelo J., Bonhomme F., Geiger S., and Ghermani N.E. Crystal and electronic structures of magnesium(II), copper(II), and mixed magnesium(II)-copper(II) complexes of the quinoline half of styrylquinoline-type HIV-1 integrase inhibitors. J. Phys. Chem. B 111 (2007) 6042-6050
16. Craigie R., Fujiwara T., and Bushman F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62 (1990) 829-837
17. Diamond T.L., and Bushman F.D. Role of metal ions in catalysis by HIV integrase analyzed using a quantitative PCR disintegration assay. Nucleic Acids Res. 34 (2006) 6116-6125
18. Doak T.G., Doerder F.P., Jahn C.L., and Herrick G. A proposed superfamily of transposase genes: transposon-like elements in ciliated protozoa and a common "D35E" motif. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 942-946
19. Dong J., Dubay J.W., Perez L.G., and Hunter E. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J. Virol. 66 (1992) 865-874
20. Drelich M., Wilhelm R., and Mous J. Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro. Virology 188 (1992) 459-468
21. Dyda F., Hickman A.B., Jenkins T.M., Engelman A., Craigie R., and Davies D.R. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 266 (1994) 1981-1986
22. Ellison V., Abrams H., Roe T., Lifson J., and Brown P. Human immunodeficiency virus integration in a cell-free system. J. Virol. 64 (1990) 2711-2715
23. Engelman A., and Craigie R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66 (1992) 6361-6369
24. Engelman A., Englund G., Orenstein J.M., Martin M.A., and Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69 (1995) 2729-2736
25. Engelman E. In vivo analysis of retroviral integrase structure and function. Adv. Virus Res. 52 (1999) 411-426
26. Esposito D., and Craigie R. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J. 17 (1998) 5832-5843
27. Farnet C.M., and Haseltine W.A. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4164-4168
28. Fayet O., Ramond P., Polard P., Prere M.F., and Chandler M. Functional similarities between retroviruses and the IS3 family of bacterial insertion sequences?. Mol. Microbiol. 4 (1990) 1771-1777
29. Fujiwara T., and Craigie R. Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 3065-3069
30. Gerton J.L., Ohgi S., Olsen M., Derisi J., and Brown P.O. Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions. J. Virol. 72 (1998) 5046-5055
31. Goldgur Y., Craigie R., Cohen G.H., Fujiwara T., Yoshinaga T., Fujishita T., Sugimoto H., Endo T., Murai H., and Davies D.R. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13040-13043
32. Goldgur Y., Dyda F., Hickman A.B., Jenkins T.M., Craigie R., and Davies D.R. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9150-9154
33. Greenwald J., Le V., Butler S.L., Bushman F.D., and Choe S. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity. Biochemistry 38 (1999) 8892-8898
34. Grobler J.A., Stillmock K., Hu B., Witmer M., Felock P., Espeseth A.S., Wolfe A., Egbertson M., Bourgeois M., Melamed J., Wai J.S., Young S., Vacca J., and Hazuda D.J. Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6661-6666
35. Haren L., Ton-Hoang B., and Chandler M. Integrating DNA: transposases and retroviral integrases. Annu. Rev. Microbiol. 53 (1999) 245-281
36. Harper A.L., Skinner L.M., Sudol M., and Katzman M. Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection. J. Virol. 75 (2001) 7756-7762
37. Harper A.L., Sudol M., and Katzman M. An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA. J. Virol. 77 (2003) 3838-3845
38. Heuer T.S., and Brown P.O. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking. Biochemistry 36 (1997) 10655-10665
39. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26 (1967) 365-371
40. 2+. Biochemistry 17 (1978) 131-138
41. 2+ and deoxynucleoside monophosphate incorporation into transcripts. Biochemistry 36 (1997) 13718-13728
42. Johnson A.A., Santos W., Pais G.C., Marchand C., Amin R., Burke Jr. T.R., Verdine G., and Pommier Y. Integration requires a specific interaction of the donor DNA terminal 5¢-cytosine with glutamine 148 of the HIV-1 integrase flexible loop. J. Biol. Chem. 281 (2006) 461-467
43. Katz R.A., Greger J.G., Darby K., Boimel P., Rall G.F., and Skalka A.M. Transduction of interphase cells by avian sarcoma virus. J. Virol. 76 (2002) 5422-5434
44. Katz R.A., Merkel G., Kulkosky J., Leis J., and Skalka A.M. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63 (1990) 87-95
45. Katzman M., Katz R.A., Skalka A.M., and Leis J. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol. 63 (1989) 5319-5327
46. Katzman M., and Sudol M. In vitro activities of purified visna virus integrase. J. Virol. 68 (1994) 3558-3569
47. Katzman M., and Sudol M. Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases. J. Virol. 69 (1995) 5687-5696
48. Katzman M., and Sudol M. Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases. J. Virol. 70 (1996) 2598-2604
49. Katzman M., Sudol M., Pufnock J.S., Zeto S., and Skinner L.M. Mapping target site selection for the non-specific nuclease activities of retroviral integrase. Virus Res. 66 (2000) 87-100
50. Kawasuji T., Fuji M., Yoshinaga T., Sato A., Fujiwara T., and Kiyama R. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors. Bioorg. Med. Chem. 14 (2006) 8420-8429
51. Khan E., Mack J.P.G., Katz R.A., Kulkosky J., and Skalka A.M. Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res. 19 (1991) 851-860
52. Konsavage Jr. W.M., Burkholder S., Sudol M., Harper A.L., and Katzman M. A substitution in Rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities. J. Virol. 79 (2005) 4691-4699
53. Konsavage Jr. W.M., Sudol M., Lee N.E., and Katzman M. Retroviral integrases that are improved for processing but impaired for joining. Virus Res. 125 (2007) 198-210
54. Krementsova E., Giffin M.J., Pincus D., and Baker T.A. Mutational analysis of the Mu transposase. Contributions of two distinct regions of domain II to recombination. J. Biol. Chem. 273 (1998) 31358-31365
55. Kulkosky J., Jones K.S., Katz R.A., Mack J.P.G., and Skalka A.M. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol. 12 (1992) 2331-2338
56. Kulkosky J., Katz R.A., Merkel G., and Skalka A.M. Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase. Virology 206 (1995) 448-456
57. LaFemina R.L., Schneider C.L., Robbins H.L., Callahan P.L., LeGrow K., Roth E., Schleif W.A., and Emini E.A. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J. Virol. 66 (1992) 7414-7419
58. Leavitt A.D., Robles G., Alesandro N., and Varmus H.E. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 70 (1996) 721-728
59. Leavitt A.D., Shiue L., and Varmus H.E. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J. Biol. Chem. 268 (1993) 2113-2119
60. Lee D.J., and Robinson Jr. W.E. Preliminary mapping of a putative inhibitor-binding pocket for human immunodeficiency virus type 1 integrase inhibitors. Antimicrob. Agents Chemother. 50 (2006) 134-142
61. Lee M.C., Deng J., Briggs J.M., and Duan Y. Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants. Biophys. J. 88 (2005) 3133-3146
62. Lins R.D., Briggs J.M., Straatsma T.P., Carlson H.A., Greenwald J., Choe S., and McCammon J.A. Molecular dynamics studies on the HIV-1 integrase catalytic domain. Biophys. J. 76 (1999) 2999-3011
63. Lins R.D., Straatsma T.P., and Briggs J.M. Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding. Biopolymers 53 (2000) 308-315
64. Lu R., Ghory H.Z., and Engelman A. Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase. J. Virol. 79 (2005) 10356-10368
65. Lubkowski J., Dauter Z., Yang F., Alexandratos J., Merkel G., Skalka A.M., and Wlodawer A. Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant. Biochemistry 38 (1999) 13512-13522
66. Lubkowski J., Yang F., Alexandratos J., Merkel G., Katz R.A., Gravuer K., Skalka A.M., and Wlodawer A. Structural basis for inactivating mutations and pH-dependent activity of avian sarcoma virus integrase. J. Biol. Chem. 273 (1998) 32685-32689
67. Lubkowski J., Yang F., Alexandratos J., Wlodawer A., Zhao H., Burke T.R.J., Neamati N., Pommier Y., Merkel G., and Skalka A.M. Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4831-4836
68. Maignan S., Guilloteau J.-P., Zhou-Liu Q., Clément-Mella C., and Mikol V. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. J. Mol. Biol. 282 (1998) 359-368
69. Moreau K., Faure C., Verdier G., and Ronfort C. Analysis of conserved and non-conserved amino acids critical for ALSV (Avian leukemia and sarcoma viruses) integrase functions in vitro. Arch. Virol. 147 (2002) 1761-1778
70. Morgan A.L., and Katzman M. Subterminal viral DNA nucleotides as specific recognition signals for human immunodeficiency virus type 1 and visna virus integrases under magnesium-dependent conditions. J. Gen. Virol. 81 (2000) 839-849
71. Moscovici C., Moscovici M.G., Jimenez H., Lai M.M.C., Hayman M.J., and Vogt P.K. Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11 (1977) 95-103
72. Muller B., and Krausslich H.G. Characterization of human T-cell leukemia virus type I integrase expressed in Escherichia coli. Eur. J. Biochem. 259 (1999) 79-87
73. Neamati N., Hong H., Owen J.M., Sunder S., Winslow H.E., Christensen J.L., Zhao H., Burke Jr. T.R., Milne G.W., and Pommier Y. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. J. Med. Chem. 41 (1998) 3202-3209
74. Pahl A., and Flugel R.M. Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus. J. Virol. 67 (1993) 5426-5434
75. Pemberton I.K., Buckle M., and Buc H. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II). J. Biol. Chem. 271 (1996) 1498-1506
76. Puglia J., Wang T., Smith-Snyder C., Cote M., Scher M., Pelletier J.N., John S., Jonsson C.B., and Roth M.J. Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins. J. Virol. 80 (2006) 9497-9510
77. Rowland S.J., and Dyke K.G. Tn552, a novel transposable element from Staphylococcus aureus. Mol. Microbiol. 4 (1990) 961-975
78. Schaefer-Klein J., Givol I., Barsov E.V., Whitcomb J.M., VanBrocklin M., Foster D.N., Federspiel M.J., and Hughes S.H. The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology 248 (1998) 305-311
79. Sechi M., Bacchi A., Carcelli M., Compari C., Duce E., Fisicaro E., Rogolino D., Gates P., Derudas M., Al-Mawsawi L.Q., and Neamati N. From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes. J. Med. Chem. 49 (2006) 4248-4260
80. Skinner L.M., Sudol M., Harper A.L., and Katzman M. Nucleophile selection for the endonuclease activities of human, ovine, and avian retroviral integrases. J. Biol. Chem. 276 (2001) 114-124
81. Snasel J., Krejcik Z., Jencova V., Rosenberg I., Ruml T., Alexandratos J., Gustchina A., and Pichova I. Integrase of Mason-Pfizer monkey virus. FEBS J 272 (2005) 203-216
82. Sotriffer C.A., Ni H., and McCammon J.A. Active site binding modes of HIV-1 integrase inhibitors. J. Med. Chem. 43 (2000) 4109-4117
83. Spidel J.L., Wilson C.B., Craven R.C., and Wills J.W. Genetic studies of the beta-hairpin loop of Rous sarcoma virus capsid protein. J. Virol. 81 (2007) 1288-1296
84. Tchertanov L., and Mouscadet J.F. Target recognition by catechols and beta-ketoenols: potential contribution of hydrogen bonding and Mn/Mg chelation to HIV-1 integrase inhibition. J. Med. Chem. 50 (2007) 1133-1145
85. van den Ent F.M.I., Vos A., and Plasterk R.H.A. Mutational scan of the human immunodeficiency virus type 2 integrase protein. J. Virol. 72 (1998) 3916-3924
86. van Gent D.C., Oude Groeneger A.A.M., and Plasterk R.H.A. Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 9598-9602
87. van Gent D.C., Oude Groeneger A.A.M., and Plasterk R.H.A. Identification of amino acids in HIV-2 integrase involved in site-specific hydrolysis and alcoholysis of viral DNA termini. Nucleic Acids Res. 21 (1993) 3373-3377
88. Vermote C.L.M., and Halford S.E. EcoR V restriction endonuclease: communication between catalytic metal ions and DNA recognition. Biochemistry 31 (1992) 6082-6089
89. Vincent K.A., Ellison V., Chow S.A., and Brown P.O. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J. Virol. 67 (1993) 425-437
90. Vink C., Oude Groeneger A.A.M., and Plasterk R.H.A. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type 1 integrase protein. Nucleic Acids Res. 21 (1993) 1419-1425
91. Vink C., van der Linden K.H., and Plasterk R.H.A. Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli. J. Virol. 68 (1994) 1468-1474
92. Wielens J., Crosby I.T., and Chalmers D.K. A three-dimensional model of the human immunodeficiency virus type 1 integration complex. J. Comput. Aided Mol. Des. 19 (2005) 301-317
93. Wiskerchen M., and Muesing M.A. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 69 (1995) 376-386
94. Yang Z.-N., Mueser T.C., Bushman F.D., and Hyde C.C. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. J. Mol. Biol. 296 (2000) 535-548